Clinical Trials Browser

Phase 2 × INDUSTRY × Extensive Stage Small Cell Lung Cancer (ES-SCLC) × Clear all

NCT06052423 2024-03-04

ARTEMIS-007: HS-20093 in Patients With Extensive Stage Small Cell Lung Cancer

Phase 2 Withdrawn

Extensive Stage Small Cell Lung Cancer (ES-SCLC)